Johnson & Johnson shares jumped to their highest price in more than three months as the US-based healthcare group shrugged ...

Johnson & Johnson (NYSE:JNJ) is one of the stocks that Jim Cramer shared insights on. Cramer discussed the company stock in ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

We recently published 14 Stocks Jim Cramer Discussed As He Talked About Record Bitcoin Price. Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer recently discussed. Johnson & Johnson ...

Dallas-based Dean Omar Branham Shirley is handling another talcum powder trial against Johnson & Johnson, which began on ...

J&J's diversified business, robust pipeline, and strong free cash flow provide stability, despite legal challenges. Read more ...

Investigative journalist Gardiner Harris exposes Johnson & Johnson's dark secrets in his eye-opening book. Available on ...

Johnson & Johnson's Pharma and Medtech Segments Combine for One of the Widest Healthcare Moats Johnson & Johnson stands alone as a leader across the major healthcare industries. It maintains a diverse ...

"No More Tears," by Gardiner Harris, is a scathing expose of Johnson & Johnson and its many missteps and transgressions.

Johnson & Johnson offers stability with 62 years of dividend growth and a 3.44% yield. Click for why JNJ is undervalued and poised for potential 65% upside.

When a large number of people are harmed by the same product, drug, or event, individual lawsuits may seem overwhelming and ...